ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 41 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $47,000 | -66.7% | 68,317 | -41.5% | 0.01% | -53.3% |
| Q4 2015 | $141,000 | -78.3% | 116,773 | -59.9% | 0.02% | -76.2% |
| Q3 2015 | $649,000 | +40.8% | 291,022 | +47.0% | 0.06% | +40.0% |
| Q2 2015 | $461,000 | +35.2% | 197,961 | +55.1% | 0.04% | +50.0% |
| Q3 2014 | $341,000 | -74.6% | 127,615 | -64.6% | 0.03% | -71.7% |
| Q2 2014 | $1,344,000 | -37.5% | 360,260 | +97.0% | 0.11% | -25.4% |
| Q1 2014 | $2,151,000 | +337.2% | 182,883 | +210.0% | 0.14% | +517.4% |
| Q4 2013 | $492,000 | – | 58,996 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 396,104 | $400,000 | 0.42% |
| Ancora Advisors LLC | 50,865 | $51,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 145,710 | $146,000 | 0.00% |
| Acrospire Investment Management LLC | 5,200 | $5,000 | 0.00% |
| A.R.T. Advisors, LLC | 57,954 | $57,000 | 0.00% |
| Renaissance Technologies | 876,100 | $876,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 4,600 | $5,000 | 0.00% |
| Cutler Group LLC / CA | 11,048 | $11,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 133,846 | $134,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 46,100 | $46,000 | 0.00% |